Add office photos
Engaged Employer
Cipla
4.1
based on 6.8k Reviews
Video summary
Proud winner of ABECA 2024 - AmbitionBox Employee Choice Awards
Company Overview
Associated Companies
Company Locations
Working at Cipla
Company Summary
Cipla is a leading Global Pharmaceutical Company that ensures access to quality & affordable medicines through various products across various therapeutic categories.
Overall Rating
4.1/5
based on 6.8k reviews

5% above
industry average

Highly rated for
Salary, Skill development, Company culture
Work Policy

Work from office
73% employees reported

Alternate Saturday off
37% employees reported

Flexible timing
56% employees reported

Within city
39% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
598 employees reported
Health insurance
570 employees reported
Office cab/shuttle
272 employees reported
Professional degree assistance
194 employees reported
View all benefits
About Cipla
Founded in1935 (90 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersMumbai, Maharashtra, India
Office Locations
Websitecipla.com
Primary Industry
Other Industries

View in video summary
At Cipla, we constantly work towards ensuring access to high quality and affordable medicines to support patients in need. Which is why, we have been trusted by health care professionals and patients across geographies for the last 8 decades. Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.
AmbitionBox Best Places to Work in India Awards
Best of the best, rated by employees
Cipla won India’s Largest Employee Choice Awards in Large Companies Category.
#2 Top Rated Pharma Company
Share
Cipla Ratings
based on 6.8k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
3.4k
4
1.8k
3
822
2
290
1
455
Category Ratings
4.0
Salary
4.0
Skill development
3.9
Company culture
3.9
Work-life balance
3.8
Work satisfaction
3.7
Job security
3.6
Promotions
Cipla is rated 4.1 out of 5 stars on AmbitionBox, based on 6.8k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Cipla
based on 6.4k reviews
4.1
Rated by 674 Women
Rated 3.9 for Work-life balance and 3.8 for Company culture
4.1
Rated by 5.7k Men
Rated 4.0 for Salary and 4.0 for Skill development
Work Policy at Cipla
based on 727 reviews in last 6 months
Work from office
73%
Hybrid
23%
Permanent work from home
4%
Cipla Reviews
Top mentions in Cipla Reviews
+ 5 more
Compare Cipla with Similar Companies
Change Company | Change Company | Change Company | ||
---|---|---|---|---|
Overall Rating | 4.1/5 based on 6.8k reviews | 4.2/5 based on 6k reviews | 4.0/5 based on 5.7k reviews | 5.0/5 based on 1 reviews |
Highly Rated for | Skill development Salary Work-life balance | Skill development Company culture Work-life balance | Salary Skill development Job security | Skill development Work-life balance Salary |
Critically Rated for | No critically rated category | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 73% employees reported | Work from office 85% employees reported | Work from office 81% employees reported | - |
Rating by Women Employees | 4.1 Good rated by 674 women | 4.0 Good rated by 358 women | 4.0 Good rated by 432 women | - no rating available |
Rating by Men Employees | 4.1 Good rated by 5.7k men | 4.2 Good rated by 5.3k men | 4.0 Good rated by 5k men | - no rating available |
Job security | 3.7 Good | 3.7 Good | 3.8 Good | 4.0 Good |
View more
Cipla Salaries
Cipla salaries have received with an average score of 4.0 out of 5 by 6.8k employees.
Deputy Manager
(1.1k salaries)
Unlock
₹5.3 L/yr - ₹18.3 L/yr
Area Business Manager
(608 salaries)
Unlock
₹4.4 L/yr - ₹12 L/yr
Therapy Manager
(502 salaries)
Unlock
₹2.4 L/yr - ₹7.1 L/yr
Medical Representative
(284 salaries)
Unlock
₹1.3 L/yr - ₹7 L/yr
Regional Business Manager
(276 salaries)
Unlock
₹8 L/yr - ₹19 L/yr
Production Officer
(236 salaries)
Unlock
₹1.1 L/yr - ₹9.8 L/yr
Trainee
(196 salaries)
Unlock
₹1 L/yr - ₹4.5 L/yr
Maintenance Engineer
(192 salaries)
Unlock
₹1.5 L/yr - ₹6.4 L/yr
Area Sales Manager
(188 salaries)
Unlock
₹4.5 L/yr - ₹11.1 L/yr
Scientific Business Manager
(170 salaries)
Unlock
₹4.5 L/yr - ₹10.8 L/yr
Cipla Interview Questions
Interview questions by designation
Top Cipla interview questions and answers
Get interview-ready with top interview questions
Cipla Jobs
Current Openings
Cipla News
View all
Glenmark’s US plant to gain amid geopolitical shifts, says CMD
- Glenmark's US plant expected to benefit from geopolitical shifts.
- Cipla and Piramal Pharma also highlight the advantages of having facilities in the US.
- Glenmark optimistic about US market with upcoming product launches.
- In India, Glenmark plans to launch more GLP-1 products for diabetes treatment.
HinduBusinessLine | 17 Feb, 2025
InTime Fire Appliances Pvt. Ltd. Leads the Charge in Comprehensive Fire Safety Solutions Across India
- InTime Fire Appliances Pvt. Ltd. is a pioneer in fire safety solutions in India.
- The company offers tailored fire safety solutions for diverse industries, focusing on quality, innovation, and customer-centricity.
- Their expertise includes clean agent systems, kitchen hood fire suppression systems, lithium battery fire extinguishers, and more.
- InTime Fire Appliances Pvt. Ltd. serves renowned clients such as Tata Steel, Cipla, HDFC, ONGC, and PVR.
Startupreporter | 13 Feb, 2025

Sensex, Nifty extend gains on Metal, Pharma rally; IT stocks drag
- Metal and pharmaceutical stocks led the rally, with Tata Steel emerging as the top gainer on the NSE, surging 3.79%.
- The healthcare sector saw strong performance from Sun Pharma and Cipla, advancing 2.77% and 2.68% respectively.
- Financial stocks, including Bajaj Finance and Bajaj Finserv, also contributed significantly to the gains.
- However, the technology sector faced selling pressure, with major IT companies trading in the red.
HinduBusinessLine | 13 Feb, 2025

Gland Pharma Share Price Target 2025 2026 to 2030
- Hyderabad-based pharmaceutical company Gland Pharma supplies injectables to over sixty countries.
- Gland Pharma shares have seen both short-term and long-term investors, and the stock's performance is under close observation.
- The Gland Pharma Share Price Target for 2025 is predicted to be between INR 1,813 to INR 2,827.
- From 2026 to 2030, Gland Pharma's share price target is projected at a minimum of INR 2,318 and a maximum of INR 6,680.08 in 2030.
- Gland Pharma's competitors include Sun Pharma, CIPLA, Divis Labs, and Dr. Reddys Labs.
- Gland Pharma's share price history isn't very long, having been listed on the National Stock Exchange in 2020.
- On August 13th, 2021, the GLAND NSE stock hit its highest point of INR 4,287.
- Consulting expert advice for the stock market predictions is advisable, as the values provided in the article are based on predictions and may not be accurate.
- Investors would need to consider verified information from other sources to make informed decisions about their investments.
- The article includes the projected maximum and minimum prices for Gland Pharma share for every month in 2025 and year-wise projection for 2026 to 2030.
VIE Stories | 10 Feb, 2025

Nifty 50 Top Gainers And Losers On Feb. 6: Cipla, ITC To Trent
- Shares of ITC Hotels Ltd., Cipla Ltd. and Adani Ports & Special Economic Zone Ltd. were the top gainers among the NSE Nifty 50 stocks on Tuesday.
- Among the losers were shares of Trent Ltd., Bharat Electronics Ltd., Bharti Airtel Ltd., Titan Co., and NTPC Ltd.
- The NSE Nifty 50 closed 0.39% down at 23,603.35, while the BSE Sensex was 0.27% lower at 78,058.16.
- The NSE Nifty 50 and BSE Sensex closed lower for the second consecutive session on Thursday, as market participants awaited the outcome of the Reserve Bank of India’s Monetary Policy Committee meeting.
Bloomberg Quint | 6 Feb, 2025

Markets extend losses, Sensex down 298 points; ITC Hotels, Cipla buck trend
- Markets extend losses, Sensex down 298 points.
- ITC Hotels and Cipla gain, while Titan Company leads the losses.
- Nifty Bank and Nifty Midcap Select index decline.
- Tata Steel records highest trading volume among top losers.
HinduBusinessLine | 6 Feb, 2025

Stocks that will see action today: February 4, 2025
- Sun Pharmaceuticals promotes Aalok Shanghvi as Chief Operating Officer.
- JTL Industries establishes new facility for manufacturing lattice towers.
- Solex Energy commissions new 800 MW production line for manufacturing TOPcon rectangular cell-based modules.
- Cipla Ltd to invest ZAR 900 million in equity share capital of its South African arm Cipla Medpro South Africa Proprietary Ltd.
HinduBusinessLine | 4 Feb, 2025

Stocks To Watch: Power Grid, Welspun Enterprises, Cipla, HFCL, KEC International And More
- Power Grid Corp announced an interim dividend of Rs 3.25 apiece with a consolidated net profit decline in Q3.
- Premier Energies' consolidated net profit jumped nearly sixfold in Q4 2024.
- Welspun Enterprises approved the sale of a 19% stake and reported a 13% consolidated net profit decline in Q3.
- Cipla will invest Rs 415 crore in its South African subsidiary.
Bloomberg Quint | 4 Feb, 2025

Markets extend gains led by Cipla, Power Grid; Tata Motors drops 6%
- Market breadth remained positive with 2,384 stocks advancing compared to 1,381 declines on the BSE, while 142 shares remained unchanged.
- Pharmaceutical major Cipla led the gainers on the NSE, rising 3 per cent, followed by Power Grid and Mahindra & Mahindra, both advancing 2.76 per cent.
- However, automotive giant Tata Motors continued its decline from morning trade, falling 6.20 per cent to become the session’s biggest loser.
- The market’s positive sentiment came despite continued selling by Foreign Institutional Investors (FIIs) and ahead of the Reserve Bank of India’s upcoming monetary policy meeting on February 7, where investors await potential signals on interest rate trajectory.
HinduBusinessLine | 30 Jan, 2025

Markets open lower after strong rally; auto, IT stocks in focus
- Markets open lower after strong rally; auto, IT stocks in focus
- ONGC, Trent, Tata Motors, Titan, and NTPC were the top gainers, while Hero MotoCorp, Tech Mahindra, Cipla, Infosys, and TCS were the top losers.
- The market opened cautiously following a strong rally on Thursday, driven by buying interest in blue-chip stocks.
- Positive market sentiment is attributed to strong December sales data from automakers and optimism ahead of the Union Budget announcement.
HinduBusinessLine | 3 Jan, 2025

Powered by
Cipla Subsidiaries
Cipla Health
4.2
• 301 reviews
Report error
Compare Cipla with
Biocon Limited
3.9
Zydus Lifesciences
4.1
Glenmark Pharmaceuticals
3.9
Torrent Pharmaceuticals
3.9
Aurobindo Pharma
4.0
DIVI'S Laboratories
3.8
Alkem Laboratories
3.9
Dr. Reddy's
4.1
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.2
Abbott
4.1
Alembic Pharmaceuticals
4.0
Ipca Laboratories
3.9
MSN Laboratories
3.7
Ajanta Pharma
4.1
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
Contribute & help others!
You can choose to be anonymous
Companies Similar to Cipla
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.7k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.9k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.8k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.7k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.4k reviews
Alkem Laboratories
Healthcare / Pharma, Biotechnology, Pharma
3.9
• 2.8k reviews
Dr. Reddy's
Clinical Research, Pharma
4.1
• 6.7k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.4k reviews
Cipla FAQs
When was Cipla founded?
Cipla was founded in 1935. The company has been operating for 90 years primarily in the Pharma sector.
Where is the Cipla headquarters located?
Cipla is headquartered in Mumbai, Maharashtra. It operates in 2 cities such as Mumbai, Hyderabad / Secunderabad. To explore all the office locations, visit Cipla locations.
How many employees does Cipla have in India?
Cipla currently has more than 25,000+ employees in India. Marketing & Communication department appears to have the highest employee count in Cipla based on the number of reviews submitted on AmbitionBox.
Does Cipla have good work-life balance?
Cipla has a Work-Life Balance Rating of 3.9 out of 5 based on 6,800+ employee reviews on AmbitionBox. 77% employees rated Cipla 4 or above, while 23% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Cipla work-life balance reviews for more details
Is Cipla good for career growth?
Career growth at Cipla is rated fairly well, with a promotions and appraisal rating of 3.6. 77% employees rated Cipla 4 or above, while 23% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Cipla promotions/appraisals reviews for more detailed insights.
What are the pros of working in Cipla?
Working at Cipla offers several advantages that make it an appealing place for employees. The company is highly rated for salary & benefits, skill development and company culture, based on 6,800+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app